OVA-LEAK:卵巢癌手术患者结直肠吻合口漏预后评分
本研究为回顾性多中心队列研究,纳入2011年1月至2021年6月因原发晚期或复发卵巢癌行肿瘤细胞减灭术并结直肠切除吻合的患者,在新独立队列中验证OVA-LEAK评分预测吻合口漏的性能。848例纳入分析,AUC为0.63;以22.1%为阳性界值时,敏感性0.45、特异性0.80、阳性预测值0.09、阴性预测值0.97。与主观临床标准相比,使用预测模型可改善对获益于转流性回肠造口患者的选择,且不增加造口率。
要点
- OVA-LEAK评分在新队列中预测吻合口漏的AUC为0.63。
- 以22.1%为界值,22.5%患者接受转流性回肠造口,47%(18/40)的漏被造口保护。
- 仅用临床标准时,12.5%(5/40)的漏被造口保护,造口率为24.3%。
核心结论
- 与主观临床标准相比,使用吻合口漏预测模型可改善对获益于转流性回肠造口患者的选择,且不增加造口使用率。
研究设计与样本
- 回顾性、多中心队列研究,纳入2011年1月至2021年6月因原发晚期或复发卵巢癌行肿瘤细胞减灭术并结直肠切除吻合的患者。
- 已纳入既往预测模型的患者数据未纳入本分析;最终848例(共招募1159例)纳入多变量逻辑回归模型验证。
- 使用OVA-LEAK公式在新独立队列中估计漏概率,行受试者工作特征(ROC)分析,以曲线下面积(AUC)衡量模型性能,并估计Brier评分及95%置信区间(CI)。
主要发现
- 新队列预测吻合口漏的AUC为0.63。
- 以22.1%为阳性界值(预测发生漏),敏感性0.45、特异性0.80、阳性预测值0.09、阴性预测值0.97。
- 以该界值选择高危患者行肠道转流时,22.5%的样本患者接受转流性回肠造口,47%(18/40)的吻合口漏被造口保护。
- 仅依据临床标准决定是否行转流性回肠造口时,仅12.5%(5/40)的漏被造口保护,转流性回肠造口率为24.3%。
关键数值与推荐
- OVA-LEAK评分以22.1%为阳性界值时,敏感性0.45、特异性0.80、阳性预测值0.09、阴性预测值0.97。
- 使用OVA-LEAK评分选择转流性回肠造口:22.5%患者接受造口,47%(18/40)的漏被保护。
- 仅用临床标准:12.5%(5/40)的漏被保护,造口率24.3%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of the present study was to define and validate an anastomotic leak prognostic score based on previously described and reported anastomotic leak risk factors (OVA-LEAK: https://n9.cl/ova-leakscore) and to establish if the use of OVA-LEAK score is better than clinical criteria (surgeon's choice) selecting anastomosis to be protected with a diverting ileostomy. MATERIAL & METHODS: This is a retrospective, multicentre cohort study that included patients who underwent cytoreductive surgery for primary advanced or relapsed ovarian cancer with colorectal resection and anastomosis between January 2011 and June 2021. Data from patients already included in the previous predictive model were not considered in the present analysis. To validate the performance of our logistic regression model, we used the OVA-LEAK formula (Annex I: https://n9.cl/ova-leakscore) for estimating leakage probabilities in a new independent cohort. Then, receiver operating characteristic (ROC) analysis was performed and area under the curve (AUC) was used to measure the performance of the model. Additionally, the Brier score was also estimated. 95% confidence intervals (CI) for each of the estimated performance measures were also calculated. RESULTS: 848 out of 1159 recruited patients were finally included in the multivariable logistic regression model validation. The AUC of the new cohort was 0.63 for predicting anastomotic leak. Considering a cut-off point of 22.1% to be 'positive' (to get a leak) this would provide a sensitivity of 0.45, specificity of 0.80, positive predictive value of 0.09 and negative predictive value of 0.97 for anastomotic leak. If we consider this cut-off point to select patients at risk of leak for bowel diversion, up to 22.5% of the sampled patients would undergo a diverting ileostomy and 47% (18/40) of the anastomotic leaks would be 'protected' with the stoma. Nevertheless, if we consider only the 'clinical criteria' for performing or not a diverting ileostomy, only 12.5% (5/40) of the leaks would be 'protected' with a stoma, with a rate of diverting ileostomy of up to 24.3%. CONCLUSIONS: Compared with subjective clinical criteria, the use of a predictive model for anastomotic leak improves the selection of patients who would benefit from a diverting ileostomy without increasing the rate of stoma use.
引用
- Lago V, Segarra-Vidal B, Cappucio S, et al. OVA-LEAK: Prognostic score for colo-rectal anastomotic leakage in patients undergoing ovarian cancer surgery. Gynecol Oncol. 2022. PMID: 36058743. doi:10.1016/j.ygyno.2022.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。